Ocular therapy using alpha-2 adrenergic receptor agonists having enhanced anterior clearance rates

Details for Australian Patent Application No. 2012202755 (hide)

Owner Allergan, Inc.

Inventors Burke, James A.; Hughes, Patrick M.; Chang-Lin, Joan-En

Agent Davies Collison Cave

Pub. Number AU-A-2012202755

Parent 2006244083

Filing date 10 May 2012

Wipo publication date 31 May 2012

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

24 May 2012 Complete Application Filed

31 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202755

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202756-Helix 12 directed steroidal pharmaceutical products

2012202754-Shared equity investment method and product